Movatterモバイル変換


[0]ホーム

URL:


AU2001261752A1 - Compositions and methods for treating otic, ophthalmic and nasal infections - Google Patents

Compositions and methods for treating otic, ophthalmic and nasal infections

Info

Publication number
AU2001261752A1
AU2001261752A1AU2001261752AAU6175201AAU2001261752A1AU 2001261752 A1AU2001261752 A1AU 2001261752A1AU 2001261752 AAU2001261752 AAU 2001261752AAU 6175201 AAU6175201 AAU 6175201AAU 2001261752 A1AU2001261752 A1AU 2001261752A1
Authority
AU
Australia
Prior art keywords
ophthalmic
compositions
methods
nasal infections
treating otic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001261752A
Inventor
Robert L. Abshire
Gerald Cagle
Linda L. Clark
Celeste H. Mclean
David W. Stroman
John M Yanni
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alcon Vision LLC
Original Assignee
Alcon Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alcon Laboratories IncfiledCriticalAlcon Laboratories Inc
Publication of AU2001261752A1publicationCriticalpatent/AU2001261752A1/en
Abandonedlegal-statusCriticalCurrent

Links

Classifications

Landscapes

AU2001261752A2000-05-192001-05-17Compositions and methods for treating otic, ophthalmic and nasal infectionsAbandonedAU2001261752A1 (en)

Applications Claiming Priority (3)

Application NumberPriority DateFiling DateTitle
US09/575,850US6509327B1 (en)1998-09-302000-05-19Compositions and methods for treating otic, ophthalmic and nasal infections
US095758502000-05-19
PCT/US2001/016112WO2001089496A2 (en)2000-05-192001-05-17Compositions and methods for treating otic, ophthalmic and nasal infections comprising quinolone antibiotics

Publications (1)

Publication NumberPublication Date
AU2001261752A1true AU2001261752A1 (en)2001-12-03

Family

ID=24301946

Family Applications (1)

Application NumberTitlePriority DateFiling Date
AU2001261752AAbandonedAU2001261752A1 (en)2000-05-192001-05-17Compositions and methods for treating otic, ophthalmic and nasal infections

Country Status (3)

CountryLink
US (2)US6509327B1 (en)
AU (1)AU2001261752A1 (en)
WO (1)WO2001089496A2 (en)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US6716830B2 (en)1998-09-302004-04-06Alcon, Inc.Ophthalmic antibiotic compositions containing moxifloxacin
EP1226138B1 (en)1999-10-082004-12-29Affinium Pharmaceuticals, Inc.Fab i inhibitors
WO2003088897A2 (en)*2001-04-062003-10-30Affinium Pharmaceuticals, Inc.Fab i inhibitors
US7790709B2 (en)2002-12-062010-09-07Affinium Pharmaceuticals, Inc.Heterocyclic compounds, methods of making them and their use in therapy
US7842791B2 (en)*2002-12-192010-11-30Nancy Jean BrittenDispersible pharmaceutical compositions
EP1608377B1 (en)2003-03-172008-10-01Affinium Pharmaceuticals, Inc.Pharmaceutical compositions comprising inhibitors of fab i and further antibiotics
US20050009931A1 (en)*2003-03-202005-01-13Britten Nancy JeanDispersible pharmaceutical composition for treatment of mastitis and otic disorders
US20050004098A1 (en)*2003-03-202005-01-06Britten Nancy JeanDispersible formulation of an anti-inflammatory agent
AU2004222523A1 (en)*2003-03-202004-09-30Pharmacia CorporationDispersible formulation of an anti-inflammatory agent
US20040214753A1 (en)*2003-03-202004-10-28Britten Nancy JeanDispersible pharmaceutical composition for treatment of mastitis and otic disorders
US20040202687A1 (en)*2003-04-142004-10-14Babu M.K. ManojCiprofloxacin formulations and methods of making and using the same
US20050085446A1 (en)*2003-04-142005-04-21Babu M.K. M.Fluoroquinolone formulations and methods of making and using the same
AU2004272414B2 (en)2003-09-102009-05-28Kyorin Pharmaceutical Co., Ltd.7-(4-substituted 3- cyclopropylaminomethyl-1- pyrrolidinyl) quinolonecarboxylic acid derivative
US20070020299A1 (en)2003-12-312007-01-25Pipkin James DInhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid
US20070020298A1 (en)*2003-12-312007-01-25Pipkin James DInhalant formulation containing sulfoalkyl ether gamma-cyclodextrin and corticosteroid
PT1828167E (en)2004-06-042014-10-08Debiopharm Int SaAcrylamide derivatives as antibiotic agents
AT501376B1 (en)*2005-01-172010-11-15Pregenzer Bruno GLUCCOOCORTICOID MEDICINAL PRODUCT
US8337481B2 (en)2005-01-252012-12-25Patrick SlaterMethod for treating otitis externa
US7981104B2 (en)*2005-01-252011-07-19Patrick SlaterMethod for treating otitis externa
US20090156578A1 (en)*2005-12-052009-06-18PAULS Henry3-Heterocyclylacrylamide Compounds as Fab I Inhibitors and Antibacterial Agents
EP2054422B1 (en)2006-07-202017-06-14Debiopharm International SAAcrylamide derivatives as fab i inhibitors
WO2008098374A1 (en)2007-02-162008-08-21Affinium Pharmaceuticals, Inc.Salts, prodrugs and polymorphs of fab i inhibitors
US8222407B2 (en)*2007-05-242012-07-17Kyorin Pharmaceutical Co., Ltd.Mutilin derivative having heterocyclic aromatic ring carboxylic acid structure in substituent at 14-position
ES2493641T3 (en)*2007-06-282014-09-12Cydex Pharmaceuticals, Inc. Nasal administration of aqueous corticosteroid solutions
CA2714580A1 (en)*2008-02-152009-08-20Alcon Research, Ltd.Fluoroquinolone derivatives for ophthalmic applications
RU2469726C2 (en)2008-05-142012-12-20Отономи, Инк.Corticosteroid-based composition with controlled release for treatment of ear diseases
US20100016450A1 (en)*2008-07-212010-01-21Otonomy, Inc.Controlled release delivery devices for the treatment of otic disorders
US8318817B2 (en)2008-07-212012-11-27Otonomy, Inc.Controlled release antimicrobial compositions and methods for the treatment of otic disorders
CA2765852C (en)*2009-07-022014-08-26Alcon Research, Ltd.Compositions comprising finafloxacin and methods for treating ophthalmic, otic, or nasal infections
EP2802209B1 (en)*2012-01-102020-12-02Entrx LLCOtic formulations
SMT201900411T1 (en)2012-06-192019-09-09Debiopharm Int SaProdrug derivatives of (e)-n-methyl-n-((3-methylbenzofuran-2-yl)methyl)-3-(7-oxo-5,6,7,8-tetrahydro-1,8-naphthyridin-3-yl)acrylamide
US9504691B2 (en)*2012-12-062016-11-29Alcon Research, Ltd.Finafloxacin suspension compositions
US9849126B2 (en)2013-01-032017-12-26Entrx LLCSterile otic formulations
CN105682742A (en)2013-08-272016-06-15奥德纳米有限公司Treatment of pediatric otic disorders
US11458041B2 (en)2015-10-082022-10-04Ocular Therapeutix, Inc.Punctal plug and bioadhesives
CN108778286A (en)2016-02-262018-11-09德彪药业国际股份公司Medicine for treating diabetic foot infection
US11040004B2 (en)2016-09-162021-06-22Otonomy, Inc.Otic gel formulations for treating otitis externa
CN119587480A (en)2020-02-062025-03-11视尔普斯眼科公司 Compositions and methods for treating eye diseases
KR20240142585A (en)2020-03-252024-09-30오큘라 테라퓨틱스, 인코포레이티드Ocular implant containing a tyrosine kinase inhibitor
EP4142664A4 (en)2020-04-272024-05-29Ocular Therapeutix, Inc.Methods of treating allergic conjunctivitis
ES2975148T3 (en)2020-09-242024-07-03Ocular Therapeutix Inc Sustained release biodegradable intracanalicular inserts comprising a hydrogel and cyclosporine
EP4216929A1 (en)2020-09-242023-08-02Ocular Therapeutix, Inc.Sustained release biodegradable intracanalicular inserts comprising a hydrogel and an active agent

Family Cites Families (38)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US4996335A (en)1980-07-101991-02-26Nicholas S. BodorSoft steroids having anti-inflammatory activity
US4710495A (en)1980-07-101987-12-01Otsuka Pharmaceutical Co., Ltd.Soft steroids having anti-inflammatory activity
US4670444B1 (en)1980-09-031999-02-09Bayer Agand-naphthyridine-3-carboxylic acids and antibacte7-amino-1-cyclopropyl-4-oxo-1,4-dihydro-quinoline-rial agents containing these compounds
US4730013A (en)1981-10-081988-03-08Merck & Co., Inc.Biosoluble ocular insert
US4474751A (en)1983-05-161984-10-02Merck & Co., Inc.Ophthalmic drug delivery system utilizing thermosetting gels
US4551456A (en)1983-11-141985-11-05Merck & Co., Inc.Ophthalmic use of norfloxacin and related antibiotics
US5223493A (en)1984-12-281993-06-29Alcon Laboratories, Inc.Anti-inflammatory compounds for ophthalmic use
JPH089597B2 (en)1986-01-211996-01-31杏林製薬株式会社 8-Alkoxyquinolonecarboxylic acid excellent in selective toxicity and its salt, and method for producing the same
DE3704907A1 (en)1987-02-171988-08-25Bayer Ag TOPICALLY APPLICABLE PREPARATIONS OF GYRASE INHIBITORS IN COMBINATION WITH CORTICOSTEROIDS
US5563138A (en)1987-04-161996-10-08Otsuka Pharmaceutical Company, LimitedBenzoheterocyclic compounds
US4920120A (en)1988-01-251990-04-24Warner-Lambert CompanyAntibacterial agents
US5149694A (en)1988-03-091992-09-22Alcon Laboratories, Inc.Combination of tobramycin and dexamethasone for topical ophthalmic use
DE3906365A1 (en)1988-07-151990-01-18Bayer Ag 7- (1-PYRROLIDINYL) -3-CHINOLONE AND NAPHTHYRIDONE CARBOXYLIC ACID DERIVATIVES, METHOD AND SUBSTITUTED (OXA) DIAZABICYCLOOCTANES AND NONANESE AS INTERMEDIATE PRODUCTS, AND ANTIBACTERIAL AGENTS AND FOOD ADDITIVES CONTAINING THEM
WO1990001933A1 (en)1988-08-261990-03-08Alcon Laboratories, Inc.Combination of quinolone antibiotics and steroids for topical ophthalmic use
US5360611A (en)1988-10-031994-11-01Alcon Laboratories, Inc.Pharmaceutical compositions and methods of treatment of the cornea following ultraviolet laser irradiation
US5185337A (en)1989-03-291993-02-09Otsuka Pharmaceutical Co., Ltd.Pyrroloquinoline derivatives and pharmaceutical compositions for antimicrobial use
US5164402A (en)1989-08-161992-11-17Pfizer IncAzabicyclo quinolone and naphthyridinone carboxylic acids
TW209865B (en)1992-01-101993-07-21Bayer Ag
ES2079994B1 (en)*1992-10-071996-08-01Cusi Lab PHARMACEUTICAL FORMULATION BASED ON POLYMIXINE-TRIMETOPRIM AND AN ANTI-INFLAMMATORY AGENT FOR ITS TOPICAL OPHTHALMIC AND ETHICAL USE.
DE4234078A1 (en)1992-10-091994-04-14Bayer Ag Quinolonecarboxylic acids
US5631004A (en)1993-09-301997-05-20Alcon Laboratories, Inc.Use of sustained release antibiotic compositions in ophthalmic surgical procedures
US5540930A (en)1993-10-251996-07-30Pharmos CorporationSuspension of loteprednol etabonate for ear, eye, or nose treatment
ES2079320B1 (en)1994-05-171996-10-16Cusi Lab OPHTHALMIC DISSOLUTION BASED ON A DICLOFENACO AND TOBRAMYCIN AND ITS APPLICATIONS.
DE4424369A1 (en)1994-07-111996-01-18Bayer Ag Pyrido [3,2,1.i, j] [3,1] benzoxazine derivatives
EP0782448B1 (en)1995-06-062002-03-27Bayer AktiengesellschaftNon-irritation, non-sensitizing, non-ototoxic otic antibacterial compositions
DE19546249A1 (en)1995-12-121997-06-19Bayer Ag New crystal modification of 1-cyclopropyl-7 - ([S, S] -2,8-diazabicyclo [4,3,0] non-8-yl) -6-fluoro-1,4-dihydro-8-methoxy-4 -oxo-3-quinoline carboxylic acid hydrochloride (CDCH), process for its preparation and pharmaceutical preparations containing it
WO1998006435A2 (en)1996-08-141998-02-19Vanderbilt UniversityCOMPOSITIONS OF ANTICHLAMYDIAL AGENTS FOR THE DIAGNOSIS AND MANAGEMENT OF INFECTION CAUSED BY $i(CHLAMYDIA)
CN1623533A (en)1997-09-252005-06-08拜尔公司Drug formulation with controlled release of active ingredient
US5912255A (en)1998-02-271999-06-15Bussell; LetantiaTopical fluoroquinolone antibiotics combined with benzoyl peroxide
GB9818258D0 (en)1998-08-211998-10-14Pfizer LtdAntifungal compositions
CA2307632C (en)1998-08-212007-05-22Senju Pharmaceutical Co., Ltd.Aqueous liquid pharmaceutical composition
US6395746B1 (en)1998-09-302002-05-28Alcon Manufacturing, Ltd.Methods of treating ophthalmic, otic and nasal infections and attendant inflammation
AR020661A1 (en)1998-09-302002-05-22Alcon Lab Inc A PHARMACEUTICAL COMPOSITION TOPICA OFTALMICA, OTICA OR NASAL AND THE USE OF THE SAME FOR THE MANUFACTURE OF A MEDICINAL PRODUCT
AR020660A1 (en)1998-09-302002-05-22Alcon Lab Inc ANTIBIOTIC COMPOSITIONS FOR THE TREATMENT OF EYES, EARS AND NOSE
EP1117406A1 (en)1998-09-302001-07-25Alcon Laboratories, Inc.Antibiotic compositions for treatment of the eye, ear and nose
US6093417A (en)*1999-01-112000-07-25Advanced Medical InstrumentsComposition to treat ear disorders
DE19962470A1 (en)1999-12-222001-07-12Schulz Hans Herrmann Use of chemotherapy drugs
WO2001089495A2 (en)2000-05-192001-11-29Alcon Laboratories, Inc.Antibiotic compositions containing quinolone derivatives for treatment of the eye, ear and nose

Also Published As

Publication numberPublication date
US20030069253A1 (en)2003-04-10
US6509327B1 (en)2003-01-21
WO2001089496A3 (en)2002-04-25
WO2001089496A2 (en)2001-11-29

Similar Documents

PublicationPublication DateTitle
AU2001261752A1 (en)Compositions and methods for treating otic, ophthalmic and nasal infections
AU2001228759A1 (en)Compositions and methods for treatment of neoplastic diseases with combinations of limonoids, flavonoids and tocotrienols
AU2001245437A1 (en)Lightweight methods and compositions for well treating
AU2001268564A1 (en)Alpha-glycosylceramides for treating bacterial and fungal infections
AU2001269799A1 (en)Methods for treating various eye disorders
AU2001289684A1 (en)Glass-ceramics, process for their preparation and use
AU2001239774A1 (en)Antibacterial agents and compositions, methods and systems employing same
AU2002232558A1 (en)Compounds, compositions and methods for treatment of parasitic infections
AU2001253297A1 (en)Sterilization process for air, liquid and surfaces
AU2001237939A1 (en)Methods for treating glaucoma
AU2001275085A1 (en)Methods, compounds and compositions for treating gout
AU2003296963A1 (en)Methods and compositions for treating and preventing ear infections
AU2001277824A1 (en)Antibacterial, antioxidant, immunomoduling and anticancerogenic preparation and method for using said preparation
AU2002324753A1 (en)Composition and method for treating viral infection
AU2002241670A1 (en)Method for treating glaucoma IB
AU2002353774A1 (en)Products and methods for treating microbial infections
AU2001261748A1 (en)Antibiotic compositions for treatment of the eye, ear and nose
AU2001234616A1 (en)Vaccine composition, process and methods
AU2003237088A1 (en)Compounds, compositions and methods for treating or preventing viral infections and associated diseases
AU2001249965A1 (en)Durable sb-stabilized mo+w phosphate glasses
AU2001258675A1 (en)Treating infections
AU2002350181A1 (en)Compositions and methods for viral delivery
AU2002342188A1 (en)Methods and compositions for treating flavivirus-mediated disease
AU2001211674A1 (en)Naphthomelanins, process for their preparation and compositions thereof
AU2002353915A1 (en)Methods and compositions for treating rotavirus-mediated disease

[8]ページ先頭

©2009-2025 Movatter.jp